Press Releases

CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option

Nov 21, 2019 5:31pm EST

CNS Pharmaceuticals Filed Request with FDA for Pre-IND Meeting for Berubicin

Nov 21, 2019 8:00am EST

CNS Pharmaceuticals Announces Attendance at the 24th Annual Meeting of the Society of Neuro-Oncology

Nov 20, 2019 8:00am EST

CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals

Nov 19, 2019 8:00am EST

CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock

Nov 13, 2019 4:15pm EST

CNS Pharmaceuticals Announces Pricing Of Initial Public Offering

Nov 07, 2019 8:00pm EST